PNC Financial Services Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-200
| Closed | -$592 | – | 4773 |
|
|
2024
Q2 | $592 | Hold |
200
| – | – | ﹤0.01% | 4507 |
|
|
2024
Q1 | $906 | Hold |
200
| – | – | ﹤0.01% | 4381 |
|
|
2023
Q4 | $1.14K | Hold |
200
| – | – | ﹤0.01% | 4290 |
|
|
2023
Q3 | $920 | Hold |
200
| – | – | ﹤0.01% | 4390 |
|
|
2023
Q2 | $1.29K | Hold |
200
| – | – | ﹤0.01% | 4466 |
|
|
2023
Q1 | $1.51K | Hold |
200
| – | – | ﹤0.01% | 4369 |
|
|
2022
Q4 | $2.03K | Hold |
200
| – | – | ﹤0.01% | 4249 |
|
|
2022
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 4151 |
|
|
2022
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 4170 |
|
|
2022
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 4161 |
|
|
2021
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 4057 |
|
|
2021
Q3 | $4K | Buy |
+200
| New | +$4K | ﹤0.01% | 3970 |
|